Molecular regulation of the brain natriuretic peptide gene

• Published in: Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2005-06, Vol.26 (6), p.944-956
• Main Author: LaPointe, Margot C.
• Format: Article
• Language: English
• Subjects: Animals; DNA, Complementary - metabolism; Exons; Gene expression; Gene Expression Regulation; Humans; Hypertrophy; Inflammation; Models, Biological; Models, Genetic; Mutation; Myocardial Ischemia; Natriuretic Peptide, Brain - biosynthesis; Natriuretic Peptide, Brain - genetics; Peptide; Promoter Regions, Genetic; Protein Processing, Post-Translational; Rats; Signal Transduction; Therapeutic; Tissue Distribution
• ISSN: 0196-9781; 1873-5169
• DOI: 10.1016/j.peptides.2004.08.028

After brain natriuretic peptide (BNP) was isolated in 1988, rapid progress was made in cloning its cDNA and gene, facilitating studies of tissue-specific expression and molecular regulation of gene expression. This review focuses on the molecular determinants of regulation of the rat and human BNP genes, including signaling pathways that impact on changes in gene expression and cis regulatory elements responsive to these signaling pathways. For both rat and human genes, elements in the proximal promoter (−124 to −80), including GATA, MCAT, and AP-1-like, have been shown to contribute to basal and inducible regulation. More distal elements in the human BNP gene respond to calcium signals (an NF-AT site at −927), thyroid hormone (a thyroid-responsive element at −1000), and mechanical stretch (shear stress-responsive elements at −652 and −162). Understanding how BNP is regulated by signaling molecules that are activated in the hypertrophied and ischemic heart should be useful in understanding the underlying pathology. This may lead to therapeutic strategies that prevent hypertrophy while allowing for the beneficial effects of BNP production.